Rating Change
Wells Fargo analysts initiated coverage on Pharvaris N.V. (NASDAQ:PHVS) with a Overweight rating on July 15, 2026.
new coverageNASDAQ:PHVS
Wells Fargo Initiates Coverage on Pharvaris N.V. (PHVS) with Overweight
Rating Change Wells Fargo analysts initiated coverage on Pharvaris N.V. (NASDAQ:PHVS) with a Overweight rating on July 15, 2026. Market Context Pharvaris N.V.
Market Context
Pharvaris N.V. operates in the Healthcare sector. The stock currently trades at $35.33 with a market capitalization of $1.6B.
Analyst coverage from Wells Fargo provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Pharvaris N.V..
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Pharvaris N.V.
Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Jul 15, 2026 | Wells Fargo | Overweight | N/A |
| Jun 25, 2026 | Morgan Stanley | Overweight | N/A |
| May 13, 2026 | Citizens | Market Outperform | N/A |
| Apr 09, 2026 | Wolfe Research | Outperform | N/A |
| Apr 07, 2026 | Wedbush | Outperform | N/A |
Related Tools: Analyst Ratings Dashboard | View PHVS Stock Page
Frequently Asked Questions
What does a Overweight rating mean for PHVS?
A Overweight rating from Wells Fargo reflects the analyst's outlook on Pharvaris N.V. (NASDAQ:PHVS). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the PHVS forecast page.